CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


We found 6858 result(s)

Duloxetine hydrochloride (Cymbalta)

Last Updated: February 8, 2008
Result type: Reports
Product Line: Common Drug Review
Generic Name: Duloxetine hydrochloride
Indications: Pain, Neuropathic, Diabetic

  • Brand Name: Cymbalta
  • Manufacturer: Eli Lilly Canada Inc.
  • Project Number: S0126
  • Project Status: Complete
  • Submission Type: New

Rotigotine Transdermal Patches (Neupro®) for the Treatment of Parkinson’s Disease

Last Updated: February 4, 2008
Result type: Reports

The rotigotine transdermal patch (Neupro®) is used for symptom control in Parkinson's disease. Study results indicate that rotigotine patches are effective in reducing the symptoms of early Parkinson's disease, and in reducing “off” time in advanced Parkinson's disease. Rotigotine patches offer the potential benefits of once-daily, topic...

  • Project Number: E0056

Overview of Assessments of Real-Time (Synchronous) and Asynchronous Telehealth

Last Updated: January 30, 2008
Result type: Reports

Technology Asynchronous telehealth refers to the storage of clinically important digital samples and relevant data (e.g., pictures of moles or surgical wounds and radiological images) from any location and forwarding them to a health care professional at a distant site for assessment at a convenient time. Issue Asynchronous telehealth could r...